NEW YORK (GenomeWeb News) - Applied Biosystems and BG Medicine are partnering on a research project that will use ABI technology to develop methods for enhancing the scale of biomarker development, ABI said today.
 
Under the terms of the two-year agreement, BG medicine will integrate ABI technology within its proteomic and metabolomic research pipeline, which BG terms “systems pharmacology.”  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.